drugset / Trial / NCT00327808
Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators will look at TPI-1020 safety and tolerability in mild to moderate asthmatic smoker subjects.
Timeline
- Start
- 2006-05
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 400 ug | Inhaled |
| Subject | TPI 1020 | Small molecule | 600 ug | Inhaled |